A股異動丨瑞瑪工業(002976.SZ)漲6.66% 成為德國大陸集團新項目產品定點供應商
格隆匯7月24日丨瑞瑪工業(002976.SZ)漲6.66%,報36.02元,總市值36億元。

瑞瑪工業昨日宣佈,公司近日收到全球汽車零部件供應商德國大陸集團Continental AG的通知,公司成為大陸集團BMW(寶馬汽車)新項目Retaining Plate Assy系列產品的定點供應商。根據大陸集團目前的預測訂單,在該BMW項目多媒體固定板供應週期(2022年至2029年)內,預計該項目對應的新增產品銷售額約2000萬歐元,折成人民幣約1.6億元(不含税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.